TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells

Published:2019-10 Issue: Volume:715 Page:144015
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Xu Ling,Wu Qi,Zhou Xifa,Wu Qiyong,Fang Mingming

Funder

Scientific Program of Changzhou

Scientific Program of Shandong Provincial Department of Education

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference25 articles.

1. The Cavbeta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels;Altier;Nat. Neurosci.,2011

2. Cancer statistics in China, 2015;Chen;CA Cancer J. Clin.,2016

3. RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia;van Everdink;Cancer Genet. Cytogenet.,2003

4. TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity;Gatt;Br. J. Haematol.,2013

5. Hallmarks of cancer: the next generation;Hanahan;cell,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50;Current Cancer Drug Targets;2024-04

2. Inhibition of ALKBH5 inhibits inflammation and excessive proliferation by promoting TRIM13 m6A modifications in glomerular mesangial cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-03-27

3. Tripartite motif family – its role in tumor progression and therapy resistance: a review;Current Opinion in Oncology;2024-01-16

4. E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities;Life Sciences;2024-01

5. Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape;Journal of Advanced Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3